GM Crops Cause Liver & Kidney Damage Within 3 Months
March 17, 2010
Natural News
By: E. Huff
A report published in the International Journal of Microbiology has verified once again that Monsanto’s genetically modified (GM) crops are causing severe health problems. A legal challenge issued against Monsanto forced the multi-national agriculture giant to release raw data revealing that animals fed its patented GM corn suffered liver and kidney damage within just three months.
Adding to the mounting evidence that GM crops are dangerous all around, this information provides a damning indictment against Monsanto which continually insists that its GM products are safe. Not only are GM crops proving disastrous for the environment, but study after study, including those conducted by Monsanto itself, is showing that GM foods are detrimental to health.
Monsanto’s data indicated that the company had conducted tests on three varieties of its GM corn, two of which contain the dangerous Bt protein, and one designed specifically to resist Monsanto’s Roundup herbicide. All three are widely grown in the United States while only one is currently grown in Europe.
Dr. Gilles-Eric Seralini, a French researcher from the University of Caen, was tasked with examining the data and providing a review. While stopping short of declaring GM crops to be toxic, he did emphasize that chronic negative effects were apparent and that there were “statistically significant” indications of kidney and liver damage.
The specific effects observed in test rats included a buildup of hormones in the blood, indicating that their liver and kidneys were not functioning properly. One variety of the corn led to elevated blood sugar levels and increased triglyceride levels in female rats given it.
Dr. Seralini concluded that, because GM crops are foreign substances that have never been a part of a normal diet, there is no telling what the long-term effects of consumption will be on people. In animals, significant disruption of normal bodily function has been observed even in the short term.
Genetically manipulated food crops are not fit for human consumption and should not be classified as food. No legitimate study has ever proven them to be safe or nutritious. The burden of proof is on the producers of such crops to verify their safety and, to date, all data has revealed that they are unsafe. Claims that GM foods will end world hunger are baseless, propagated only by those that have a financial interest in converting the world’s food supply to their own patented varieties in order to control it.
Click here for the full report.
Colonoscopy Prep Pills Carry Kidney Risk
October 28, 2009
USA Today
By Rita Rubin
Anyone who’s ever had a colonoscopy knows the worst part is preparing for it, not the procedure itself. You have to make sure your colon is as clean as a whistle so your doctor can get an unobstructed interior view.
In the old days — the late 20th century, that is — you had to drink a gallon of a special salty liquid to cleanse your bowels in basically one sitting. So patients cheered when tasteless tablets that would accomplish the same thing became available in 2000.
But last week, the Food and Drug Administration tempered that joy by adding a “black box” warning — the sternest warning possible — to the two prescription bowel cleansers that come in tablet form. The new warning stems from reports of kidney damage in patients who took the pills, which contain sodium phosphate, in preparation for a colonoscopy.
Also, the FDA, which can require warnings only on prescription drugs, said no over-the-counter sodium phosphate products should be used for bowel-cleansing. That led C.B. Fleet Co. to announce a voluntary recall of Phospho-soda, a non-prescription laxative that in larger doses has been used for bowel-cleansing.
The FDA says prescription Visicol, approved in 2000, and its successor, OsmoPrep, approved in 2006, should be used with caution by people over 55; those who are dehydrated; those who suffer from kidney disease, acute colitis or delayed bowel emptying; and people on medicines that affect kidney function. Medicines include diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers and, maybe, ibuprofen and other non-steroidal anti-inflammatory drugs.
Indiana University gastroenterologist Douglas Rex says he’s been switching older patients to fluid bowel-cleansers that don’t contain sodium phosphate since the first reports of kidney problems came out in 2005. Rex serves as a scientific adviser to Salix Pharmaceuticals, maker of Visicol, OsmoPrep and MoviPrep, one of the fluid products.
No one knows how many people may have suffered damage from the sodium phosphate bowel-cleansers, because even those who’ve lost 75% of their kidney function feel fine, says Columbia University pathologist Glen Markowitz. Markowitz, a Salix consultant, was lead author of a 2005 report on kidney damage in 21 patients who had taken sodium phosphate bowel-cleansers. Even when detected, he says, a connection to the products could be missed.
Dallas gastroenterologist Lawrence Schiller says a patient who had an easy time with the pills wasn’t thrilled to learn of the kidney issue. Schiller left future choice of prep up to her, noting: “There’s a one-in-a-million chance you could end up on dialysis with (the pills).”
Click here for the full report.
H1N1 Vaccines Contain Cancer Causing Ingredients
October 2, 2009
VacTruth
By Dawn Crim
Most health experts will agree that vaccine reactions can occur. It is estimated that roughly 1 in every million people will react to their vaccine. Even then, health officials maintain that it is usually a simple case of inflammation at the injection site and/or a slight fever. On a rare occasion, anaphylactic shock may occur due to the patient reacting to a substance that they are allergic to.
However, the FDA recently approved four H1N1 vaccines that not only contain very questionable ingredients, but some of those ingredients have even been proven to cause cancer and death.
The FDA has awarded H1N1 contracts to the following companies: MedImmune, LLC, CSL Limited, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur. Their package inserts became public knowledge in recent weeks.
All four vaccines list hypersensitivity to eggs as a contraindication. This means that it is not advisable to administer any one of these products to a person suffering from a severe egg allergy or egg protein allergy. This contraindication may affect as many as 15 million people (based on a population of 300 million). While parents are instructed not to feed their infant eggs until 1 year of age, these same infants will be exposed to eggs by way of their H1N1 vaccine and/or seasonal flu vaccine beginning at 6 months of age.
CSL’s vaccine also lists hypersensitivity to chicken protein as a contraindication. “While most people who are sensitive to eggs can eat chicken, there is one protein that is present in both eggs and poultry — alpha-livetin, or chicken serum albumin — that can cause allergies to both foods.” It is unknown at this time how many people are allergic to the aforementioned proteins. Going into anaphylactic shock is a very real possibly if one were to receive an ingredient that he/she is allergic to.
Neomycin and polymyxin are listed as contraindications for CSL’s and Novartis’ vaccines. “Neomycin may cause damage to the kidneys and/or nerves. Kidney function and drug levels in the blood may be monitored with blood tests during treatment. Tell your doctor if you experience decreased urination, hearing loss, ringing in the ears, feeling of fullness in the ears, dizziness, numbness, skin tingling, muscle twitching, or seizures which may be signs of kidney or nerve damage.” According to Teva Pharmaceuticals, the effects of neomycin may not be evident until long after the medication has been discontinued. Just exactly how long is unclear at this time. Polymyxin has its own set of possible adverse reactions. “Neurotoxic reactions may be manifested by irritability, weakness, drowsiness, ataxia, perioral paresthesia, numbness of the extremities, and blurring of vision. These are usually associated with high serum levels found in patients with impaired renal function and/or nephrotoxicity.”
Gentamicin is listed as a contraindication for MedImmune’s vaccine. It too, has its own list of possible side effects, which may include nephrotoxicity and/or neurotoxicity.
Nephrotoxicity is when damage or injury occurs to the kidneys as a result of taking certain medications. This may include kidney failure. Neurotoxicity is when the damage involves the nerve tissue, such as paralysis or encephalitis (brain swelling).
A word of caution to parents is warranted here: several vaccine manufacturers list crying or high-pitched screaming for greater than 3 hours as a sign of a serious vaccine reaction. Though this same warning is not applicable to any one of these H1N1 vaccines, it is still a situation that a parent should be alert to. If your child is crying or screaming for a long period of time, it may be a sign of brain inflammation. You know your child better than anyone. If something doesn’t feel right, have your child evaluated immediately.
Click here to continue reading the full report from VacTruth
Fish Oils Reduce Size of Cancer Tumors
August 6, 2009
Natural News
The omega-3 essential fatty acid known as docosahexaenoic acid (DHA) is more effective at reducing the size of breast cancer tumors than the chemotherapy drug cisplatin, and can also reduce that drug’s harmful side effects, reports a new study published in the journal Cell Division.
“Our results suggest a new, fruitful drug regimen in the management of solid tumors based on combining cisplatin and possibly other chemotherapeutics with DHA,” said researcher A.M. El-Mowafy of Egypt’s Mansoura University. “DHA elicited prominent chemo-preventative effects on its own, and appreciably augmented those of cisplatin as well. Furthermore, this study is the first to reveal that DHA can obliterate lethal cisplatin-induced nephrotoxicity [kidney damage] and renal tissue injury.”
Researchers injected a group of mice with breast cancer cells, then treated them with either 125 or 250 milligrams per kilogram of DHA, a regular dose of cisplatin, a mix of cisplatin and 125 milligrams per kilogram of DHA, or a placebo. They recorded tumor size and blood levels of white blood cells, C-reactive protein (CRP) and MDA at the start of the study and again after 20 days.
CRP is a marker of inflammation, a known risk factor for tumor growth. MDA is a marker of lipid peroxidation, which signifies high levels of the free radicals that can lead to cancer. Elevated white blood cell counts are also associated with tumor growth.
The researchers found that compared with mice that had never been injected with cancer cells, the injected mice underwent a significant increase in levels of CRP, MDA and white blood cells. Elevated levels of CRP and white blood cells were significantly correlated with increased tumor size.
Levels of white blood cells, CRP and MDA were all lower in animals that had been treated with either DHA, cisplatin, or a combination, however.
In animals who received 125 milligrams per kilogram of DHA, tumor growth was 38 percent less than in animals who received a placebo. Animals receiving cisplatin had 55 percent less tumor growth, while those treated with 250 milligrams per kilogram of DHA had 79 percent less. The combination of DHA and cisplatin not only reduced tumor growth by 81 percent compared with a placebo, it also returned white blood cell counts to normal levels. The 250 milligram per kilogram dose of DHA was nearly as effective at restoring a normal white blood cell count as the DHA-cisplatin combination.
“The chemoprevention elicited by DHA was dose-dependent, and appeared to be mediated by reduction of leukocytosis [elevated white blood cell count], oxidative stress, and replenishing of endogenous antioxidant machinery,” the researchers wrote. “Most strikingly, a strong anti-inflammatory effect was produced.”
In a second experiment, researchers treated rats with cisplatin, which is known to produce potentially lethal kidney damage. Half the rats were also given a 250 milligram per kilogram dose of DHA, while the other half was given nothing.
All the rats that received only cisplatin died from kidney toxicity. Among animals given both the drug and the omega-3, however, only 12 percent developed lethal kidney damage.
DHA is found primarily in fatty cold-water fish, such as salmon, anchovies, herring, mackerel and sardines, but it can also be found in certain vegetable oils. It is believed to play a critical role in the development of the nervous system, particularly the brain and retina.












































